The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2017
Filed:
Feb. 09, 2015
Applicant:
Janssen Diagnostics Bvba, Beerse, BE;
Inventors:
Kurt Van Baelen, Westerlo, BE;
Lieven Jozef Stuyver, Herzele, BE;
Kevin Karel Florentina Arien, Nazareth, BE;
Assignee:
Janssen Diagnostics BVBA, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); C12Q 1/02 (2006.01); C12N 7/00 (2006.01); C12Q 1/70 (2006.01); C07H 21/04 (2006.01); C07H 21/02 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/025 (2013.01); C07H 21/04 (2013.01); C12N 7/00 (2013.01); C12Q 1/703 (2013.01); C12N 2740/16021 (2013.01); C12N 2740/16031 (2013.01); C12N 2740/16043 (2013.01); C12N 2740/16051 (2013.01); G01N 2333/16 (2013.01); G01N 2500/02 (2013.01); G01N 2500/10 (2013.01);
Abstract
The instant disclosure describes a novel genotype and phenotype assay to elucidate and/or evaluate new potential HIV integrase inhibitors, but also currently approved and experimental compounds that target protease, reverse transcriptase, and RNaseH. This assay allows studying linked mutations and mutational patterns that occur under HAART and experimental therapies.